Sanofi (SNY): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Sanofi ( SNY) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.8%. By the end of trading, Sanofi fell $1.32 (-2.5%) to $51.48 on heavy volume. Throughout the day, 2,795,790 shares of Sanofi exchanged hands as compared to its average daily volume of 996,800 shares. The stock ranged in price between $51.48-$53.53 after having opened the day at $53.05 as compared to the previous trading day's close of $52.80. Other companies within the Health Care sector that declined today were: NuVasive ( NUVA), down 12.6%, InfuSystems Holdings ( INFU), down 11.8%, Stereotaxis ( STXS), down 10.4% and Organovo Holdings ( ONVO), down 8.7%.

Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Sanofi has a market cap of $141.0 billion and is part of the drugs industry. Shares are up 11.4% year to date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Sanofi a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Sanofi as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, CardioNet ( BEAT), up 38.2%, Questcor Pharmaceuticals ( QCOR), up 28.4%, Reliv' International ( RELV), up 22.0% and Hansen Medical ( HNSN), up 21.9% , were all gainers within the health care sector with Cigna ( CI) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Generic Drug Makers Hurt By Latest Federal Government Budget

Generic Drug Makers Hurt By Latest Federal Government Budget

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

Investors Are Trying to Figure Out the 'Powell Put'

Investors Are Trying to Figure Out the 'Powell Put'

Sanofi Announces Second Billion-Dollar Deal In a Week, and It May Not Be Done

Sanofi Announces Second Billion-Dollar Deal In a Week, and It May Not Be Done

5G, Sanofi, Ablynx, Coincheck and Bruno Mars - 5 Things You Must Know

5G, Sanofi, Ablynx, Coincheck and Bruno Mars - 5 Things You Must Know